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Background. Internal thoracic artery (ITA) is a very useful conduit for coronary artery 
bypass artery (CABG), with excellent long-term patency. With the purpose to dilate the ITA 
graft and increase graft free flow (GFF) intraoperatively, we evaluated the usefulness of 
intraluminal injection of fasudil, a Rho-kinase inhibitor, and compared with the conventional 
graft dilating agent papaverine.  
Methods. Between June 2011 and January 2012, 30 patients with ischemic heart disease 
who underwent isolated CABG using ITA were enrolled. The patients were randomly assigned 
to two groups: fasudil group (n=15) in which fasudil solution 0.9 mg/dl was injected into ITA, 
and papaverine group (n=15) in which papaverine solution (0.4 mg/ml) mixed with heparinized 
blood was used. Outcome measures were left ITA GFF, heart rate and mean blood pressure 
during flow measurements, and histopathological examination of ITA.  
Results. In the fasudil group, GFF increased significantly (p<0.01) from 19.7±15.2 ml/min at 
baseline to 66.9±31.7ml/min after fasudil injection. In the papaverine group, GFF increased 
significantly (p<0.01) from 22.9±17.3 ml/min at baseline to 44.8±26.7 ml/min after papaverine 
injection. Blood pressure and heart rate did not change significantly after drug injection in both 
groups. The GFF was significantly higher (p=0.038) in fasudil-treated ITA than in 
papaverine-treated ITA. Histopathologically, the diameter of the ITA was markedly increased 
after fasudil injection. Elastica van Gieson staining showed that the multiple elastic lamellae 
structure was intact. 
Conclusion. Fasudil exhibited very potent vasodilatatory effect on ITA compared to 





The internal thoracic artery (ITA) graft is an indispensable conduit for coronary artery 
bypass grafting (CABG), because superior long-term patency is obtained with the ITA graft 
compared with the traditional saphenous vein and other grafts [1]. Although the ITA graft has 
the advantage of long-term patency, there are reported cases of reduced graft flow after left 
ITA–left anterior descending artery anastomosis caused by a narrow graft or spasm during 
graft harvest, leading to worsened hemodynamics [2]. Vasodilating drugs [3, 4] and harvesting 
techniques [5] have been used to prevent or relax spasm, which have contributed to improve 
the graft flow and increase the left ITA graft patency rate.  
Fasudil is a Rho-kinase inhibitor and a vasodilator with a new mechanism of action. Due 
to its potent vasodilating action, fasudil has been used in various clinical fields. In the field of 
neurosurgery, fasudil is a very effective drug for the prevention of cerebral vasospasm, which 
is a serious complication secondary to intracranial hemorrhage.6 In cardiovascular field, 
fasudil attenuates coronary spasm, and its potential in the treatment of ischemic heart disease 
and arteriosclerosis is anticipated.7 Focusing on the potent vasodilating action of this drug and 
considering its clinical safety, we examined the usefulness of fasudil as a vasodilating agent 
for ITA graft and compared with the conventionally used papaverine.  
 
Patients and Methods 
 
Patients 
Among the patients who underwent elective CABG in our department between June 
2011 and January 2012, 30 consecutive patients using the left ITA conduit were enrolled in 
this study. Patients who had received radiotherapy in the left chest and patients who had a 
hemodialysis shunt in the forearm were excluded. All patients undergoing CABG during this 
period were eligible for entry into the trial. The trial was approved by the institutional ethics 
committee. Informed consent was obtained from each patient. 
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Patients were assigned randomly to two groups according to the agent used to dilate 
the ITA graft. In the fasudil group, fasudil solution (0.9 mg/ml) was injected into the ITA graft. In 
the papaverine group, conventional papaverine (0.4 mg/ml mixed with heparinized blood) was 
injected into the ITA graft. 
 
Protocol 
Under general anesthesia, a median sternotomy was performed, and a retractor for ITA 
harvest was placed. Using the Vallylab Force 2 (Tyco Healthcare co, USA) electro-scalpel at 
settings of Blend 2 and 20 Watts, the left ITA was isolated together with the internal thoracic 
vein using the semi-skeletonizing technique. Dissection was performed until the ITA origin 
from the subclavian artery at the proximal end, and until the bifurcation into the superior 
epigastric artery and musculophrenic artery at the distal end. After injecting heparin (150 
unit/kg), the left ITA was transected just proximal to its bifurcation.  
In both groups, baseline graft free flow (GFF) of the left ITA was measured for 60 seconds. 
After 10 min, 2 ml of fasudil solution (Asahi Kasei, Japan) diluted to 0.9 mg/ml was injected 
intraluminally into the ITA graft in the fasudil group, and 2 ml of papaverine (0.4 mg/ml mixed 
with heparinized blood) was injected into the ITA graft in the papaverine group. Ten minutes 
after injection of the vasodilator, GFF of the ITA graft was again measured for 60 seconds. 
Thereafter off-pump CABG was performed in all patients. The numbers of anastomosis 
ranged from 2 to 6 (mean, 3.2 ± 1.2). All these cases involved anastomosis of the left anterior 
descending coronary artery (LAD) with the left ITA.  
 
Outcome measures and measurement methods  
Graft free flow of the left ITA was measured by collecting free flowing blood from the 
transected ITA for 60 seconds into a special tube and expressed as ml/min. During GFF 
measurement, mean arterial pressure was recorded. Blood pressure was measured from the 




Histopathological examination  
Surplus ITA tissue of one patient in the untreated group was examined 
histopathologically. Ring specimens of the left ITA graft stump were collected before and after 
fasudil injection to examine the vasodilating effect. Hematoxylin and eosin (HE) and Elastica 
van Gieson (EvG) stained sections were evaluated qualitatively for changes in the media and 
elastic fiber, as well as the change in internal diameter.  
 
Statistical analysis 
All statistical analyses were performed using SPSS software (version 19.0.0.2; SPSS, 
Chicago, IL). All data are expressed as mean ± standard deviation. The baseline 
characteristics and hospital outcomes for the two groups were compared using χ2 test for 
categorical data, or unpaired t-test for continuous data. The fasudil group and papaverine 
group were compared with respect to pretreatment and posttreatment hemodynamic 
parameters and GFF of the left ITA graft using 2-way ANOVA. Statistical significance was 
defined as a p value less than 0.05. 
 
Results  
Demographic and hemodynamic data 
The fasudil group (n =15) consisted of 12 men and 3 women with a mean age of 70.5± 
8.3 years old, while the papaverine group (n = 15) consisted of 13 men and 2 women with a 
mean age of 68.6 ± 9.5 years, with no significant differences between two groups. 
There were no significant changes in heart rate and mean arterial pressure between two 
groups both before and after graft treatment (Table 1). No patient had perioperative 
myocardial infarction. There were no significant differences in the use of inotropic agents and 
postoperative drainage between two groups. No serious complications such as pleural 





Effects of fasudil and papaverine 
The GFF of the left ITA graft treated with fasudil increased markedly from 19.7 ± 
15.2ml/min at baseline to 66.9 ± 31.7 ml/min at 10 min after treatment, showing a significant 
increase (p = 0.01) (Fig. 1). The GFF of the left ITA graft treated with papaverine also 
increased significantly (p = 0.05) from 22.9 ± 17.3 ml/min at baseline to 44.8 ± 26.7 ml/min at 
10 min after treatment. Comparing fasudil- and papaverine-treated left ITA grafts, the GFF 
was significantly higher in the fasudil group than in the papaverine group (p = 0.038). 
Graft angiography using 3D-CT was performed in all patients after surgery. All the ITA 
grafts in both groups were patent. 
 
Histopathological findings 
We compared the histopathological findings of left ITA ring specimens collected from 
the same patient before and after fasudil injection (Fig. 2). The diameter of the ITA was 
markedly increased after fasudil injection. Elastica van Gieson staining showed that the 
structure of multiple elastic lamellae was intact. The smooth muscle-rich media became 
thinner after fasudil injection, suggesting relaxation. 
 
Comments  
In the present study, fasudil treatment of the ITA increased GFF by over 300%. This data 
greatly exceeds the maximum increase in GFF reported for papaverine (increase by 100%) 
[8], nitroglycerin and verapamil (GV) (86%) [9], and phosphodiesterase III inhibitor (PDE III) 
(59%) [10]. In the present study, there was a significant increase in GFF in papaverine-treated 
ITA grafts, showing the benefit of papaverine as a vasodilating agent. However, the 
post-treatment GFF in the papaverine group was significantly lower than in the fasudil group. 
To the best of our knowledge, this is the first study demonstrating that the Rho-kinase inhibitor 
fasudil is highly effective in dilating ITA with resultant increase in ITA graft free flow. Thus 
fasudil is an amazing vasodilating agent for ITA, with potency incomparably higher than the 
other agents. From the surgeon’s view of the operative field under a 3.5 x magnifying lens, the 
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fasudil–treated ITA graft appears dilated and relaxed, with a thin wall. In fact, when pre- and 
post-fasudil–treated ring samples of the transected ITA from the same patient were examined 
histopathologically, the vascular wall was confirmed to be thin and dilated. In the surgical field, 
since the fasudil–treated ITA graft is thin due to the potent vasodilating effect, it probably 
requires more delicate handling than in conventional procedures. 
Because of the good long-term patency rate, the ITA–LAD anastomosis is being used as 
the gold standard of CABG [1]. The good patency of the ITA led to the expectation that arterial 
grafts are superior, and other arterial conduits such as the radial artery (RA) and 
gastroepiploic artery (GEA) are also being used in CABG [11, 12]. However, the superiority of 
ITA remains unchanged. The characteristic of ITA which makes it an excellent graft is that it is 
an elastic type artery rich in elastic fiber in the media, compared with the other muscular type 
arteries such as the RA and GEA. Although the ITA, being an elastic type arterial graft, is 
expected to be less susceptible to graft spasm, report has indicated that spasm may occur 
during harvest or immediately after surgery, deteriorating perioperative hemodynamics [2]. 
Therefore appropriate intraoperative pretreatment of the ITA graft is essential to prevent or 
relax graft spasm.  
Surgeons have developed various methods attempting to eliminate the negative effects 
of graft spasm. One of them is to modify the technique of harvesting the pedicle, such as 
using skeletonization with an ultrasonic scalpel5 and treatment with various anti-spastic 
agents [3, 4, 9]. We reviewed the effects of the conventionally used drugs reported by various 
investigators. Many anti-spastic agents have been reported, including papaverine, 
nitroglycerin, GV solution and phosphodiesterase (PDE) III inhibitor [3, 4, 8-10]. According to 
reports of quantitative evaluation of free flow of ITA treated by papaverine, Formica et al. [9] 
reported a 32% increase from 40 to 53 ml/min; Koramaz et al. [8] reported 100% increase 
from 32 to 64 ml/min; Nili et al. [3] reported 10% increase from 38.8 to 42.1 ml/min; and 
Takeuchi et al. [10] reported 8% increase from 37 to 40 ml/min. For verapamil, Nili et al. [3] 
reported 7.2% increase from 33.8 to 41.1 ml/min. For nitroglycerin, Nili et al. [3] reported 2% 
increase from 38.8 to 39.2 ml/min with no significant difference; and Takeuchi et al. [10] 
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reported 27% increase from 37.9 to 47.9 ml/min. Formica et al. [9] used 
glyceril-trinitrate/verapamil and showed an 86% increase in free flow from 31.6 to 58.8 ml/min. 
Recently, the vasodilatory effect of PDE III inhibitor has attracted attention, and experimental 
data have been reported [13, 14]. Takeuchi et al. [10] used PDE III inhibitor and measured the 
GFF of ITA. They reported 59% increase from 36 to 57 ml/min, and concluded the usefulness 
of this agent. Although PDE III, papaverine, GV and nitroglycerin alone have been shown to 
have some degrees of vasodilatory effect, none of the reports indicated an increase in graft 
flow by greater than 100%.  
Rho kinase is an intracellular serine/threonine kinase identified in the mid-1990s as a 
target protein for the low molecular weight GTP-binding protein “Rho” [15, 16]. Rho kinase is 
closely associated with many physiological functions such as contraction, cell proliferation, 
cell migration, and induction of gene expression. It is known to regulate vascular smooth 
muscle contraction and relaxation independent of the intracellular calcium ion concentration. 
Rho kinase is closely involved in the pathogenesis of various diseases including 
cardiovascular disease, suggesting a possible role of Rho kinase inhibitor in the treatment of 
these diseases [7]. Selective injection of the Rho kinase inhibitor fasudil into the coronary 
artery inhibited acetylcholine-provoked coronary vasospasm, angina-related ECG change 
and chest pain [17, 18]. Fasudil treatment also markedly improves the conditions of patients 
with intractable coronary vasospasm not responding to maximum vasodilatory therapy 
immediately after CABG [19]. In the field of neurosurgery, fasudil has been shown to be useful 
in preventing cerebral vasospasm after cerebral hemorrhage. We focused on the application 
of the potent vasodilatory effect of Rho kinase inhibitor in coronary surgery, and performed a 
basic study to investigate the in vivo vasodilatory effect of the commercially available Rho 
kinase inhibitor fasudil in humans [20].  
The method of administering vasodilatory agent during CABG is an important issue. From 
the mechanism of action of the drug, three methods are plausible: (1) intraluminal injection 
(infiltration from the intima to media and then to adventitia); (2) topical application on the 
adventitia or covering with gauze soaked with the drug (infiltration from the adventitia); and (3) 
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systemic administration. Conventional vasodilatory drugs are administered empirically by the 
first or second method, alone or in combination, depending on the surgeon. For ITA, the drug 
and the administration method that provide maximum effectiveness remain unknown and the 
exact mechanism is also unclear. In the present study, to exclude the effect of drug infiltration 
from outside and the effect of systemic administration, we injected a small volume (2 ml) of 
fasudil intraluminally. Because of the small volume, the drug is unlikely to circulate 
systemically. Hence we evaluated only the effect of intraluminal administration. Our result thus 
showed that marked vasodilatation is achieved by intraluminal injection. This result is logical 
considering that the ITA has little vaso vasorum, and 80% of the blood in the arterial wall is 
directly supplied by the blood in the lumen. Studies on the effects of local application and 
systemic administration are ongoing. Fasudil is a relatively low cost drug and has a long 
history of clinical application. The performance of this drug in the neurosurgical field has been 
documented for over 10 years [6]. Therefore fasudil can be used without concern over safety.  
    When a sufficiently dilated ITA graft is used in CABG, good flow can be expected after 
surgery. This technique can be recommended from the viewpoints of perioperative 




    In this study, fasudil exhibited very potent vasodilatory effect on ITA, resulting in markedly 
increased GFF. Dilatation of the ITA wall was histologically verified. Fasudil is a highly 
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Table 1. Hemodynamic parameters before and after left internal thoracic artery graft treatment  
 
 
 Heart rate (/min) Before 
vs. after 
treatment 
Mean blood pressure 
(mmHg)  Before vs. after 







Fasudil group 75.6±12.9 76.2±13.9 NS 65.5±17.7 61.3±16.4 NS  
Papaverine group 75.9±13.5 75.7±14.3 NS 67.4±12.9 64.3±9.8 NS 
Fasudil vs. 
papaverine NS NS  NS NS  
                                    







Fig. 1. Change in graft free flow (GFF; ml/min) of left internal thoracic artery (ITA) graft before 
and after treatment with fasudil or papaverine. NS: not significant. 
 
Fig. 2. Histopathological findings of left internal thoracic artery (ITA) specimen before fasudil 
injection (A) and after fasudil injection (B). The diameter of the ITA increases markedly after 
fasudil infection. Elastica van Gieson staining. 
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